Summit
Payments companies reported to CMS as associated with Summit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Summit, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Summit
These are the largest totals companies reported as associated with Summit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daniel Berry | Rochester, MN | Orthopaedic Surgery | $8,397,885.77 |
| David Dalury | Towson, MD | Orthopaedic Surgery | $2,319,463.78 |
| David Fisher | Indianapolis, IN | Orthopaedic Surgery | $2,085,229.18 |
| John Callaghan | Iowa City, IA | Orthopaedic Surgery | $628,126.84 |
| Thomas Schmalzried | Los Angeles, CA | Orthopaedic Surgery | $540,222.52 |
| Jefferson Morrison | Nashville, TN | Orthopaedic Surgery | $157,209.70 |
| Charles Lupo | Warrenville, IL | Orthopaedic Surgery | $26,982.75 |
| Kiel Pfefferle | Akron, OH | Orthopaedic Surgery | $22,534.00 |
| Jeremy Statton | Lees Summit, MO | Orthopaedic Surgery | $10,660.00 |
| Joseph Gondusky | Virginia Beach, VA | Orthopaedic Surgery | $10,572.01 |
Prescribed Summit?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.